Mercado de terapia digital (DTx) de América del Norte y Europa, por tipo de producto y servicio (producto de hardware, soluciones/software y servicio), aplicación (aplicaciones relacionadas con el tratamiento/cuidado y aplicaciones preventivas), modo de compra (organización de compra grupal e individual), canal de ventas (B2B y B2C): tendencias de la industria y pronóstico hasta 2030.
Análisis y perspectivas del mercado de terapias digitales (DTx) en América del Norte y Europa
La terapéutica digital (DTx) ofrece terapias basadas en evidencia a los pacientes que son operadas por programas de software de alta calidad para prevenir, tratar o curar un trastorno o enfermedad médica. Se utilizan de forma individual o en combinación con medicamentos, dispositivos u otros remedios para mejorar la atención al paciente y los resultados de salud. Los productos DTx incorporan las mejores aplicaciones de tecnología avanzada en relación con el diseño, las afirmaciones clínicas, la facilidad de uso y la seguridad de los datos. Los organismos legislativos los corroboran según sea necesario para respaldar las afirmaciones de los productos en cuanto a riesgo, eficacia y uso deliberado. DTx otorga a los pacientes, proveedores de atención médica y pagadores herramientas accesibles para describir diversas afecciones a través de medicamentos seguros de alta calidad y prácticamente basados en datos.
Algunos de los actores del mercado ofrecen productos y servicios para enfermedades crónicas, que se utilizan principalmente en la población de edad avanzada. Durante los últimos años, ha surgido un nuevo software innovador que permite a las personas apegarse más a la terapia digital para facilitar su uso. Un gran número de actores del mercado participan en la prestación de servicios para mantener la terapia digital, lo que allana el camino para el crecimiento del mercado.
Teniendo en cuenta la diversidad de productos en la industria DTx, las terapias digitales individuales tienen el potencial de brindar a los pacientes, médicos y pagadores nuevas opciones de terapia para necesidades médicas no satisfechas, usarse de forma independiente o junto con otras terapias, mejorar, respaldar u optimizar los tratamientos médicos actuales, integrarse en las pautas médicas y las mejores prácticas y permitir la expansión de la atención fuera de un entorno clínico tradicional.
La demanda de terapias digitales ha aumentado tanto en los países desarrollados como en los países en desarrollo, y la razón detrás de esto es un aumento en la prevalencia de trastornos crónicos en todo el mundo. El mercado de terapias digitales (DTx) en América del Norte y Europa está creciendo debido a una mayor concienciación por parte de las organizaciones gubernamentales y al avance tecnológico en la atención médica. El mercado crecerá en el período de pronóstico con la creciente adopción de tratamientos digitales y avances tecnológicos.
Se espera que las políticas de privacidad relacionadas con la información del paciente, la opción de pago digital no aceptable y la falta de instalaciones de Internet en los países subdesarrollados limiten el crecimiento del mercado terapéutico digital (DTx) en América del Norte y Europa.
El mercado de terapia digital (DTx) de América del Norte y Europa es favorable y tiene como objetivo reducir la progresión de la enfermedad. Data Bridge Market Research analiza que el mercado de terapia digital (DTx) de América del Norte y Europa crecerá a una CAGR del 24,8 % en América del Norte y del 23,53 % en Europa durante el período de pronóstico de 2023 a 2030.
|
Métrica del informe |
Detalles |
|
Período de pronóstico |
2023 a 2030 |
|
Año base |
2022 |
|
Años históricos |
2021 (Personalizable para 2015-2020) |
|
Unidades cuantitativas |
Ingresos en millones de USD, precios en USD |
|
Segmentos cubiertos |
Por tipo de producto y servicio (producto de hardware, soluciones/software y servicio), aplicación (aplicaciones relacionadas con el tratamiento/cuidado y aplicaciones preventivas), modo de compra (organización de compra grupal e individual), canal de venta (B2B y B2C) |
|
Países cubiertos |
Estados Unidos, Canadá, México, Alemania, Reino Unido, Francia, Italia, España, Países Bajos, Rusia, Suiza, Turquía, Bélgica y el resto de Europa. |
|
Actores del mercado cubiertos |
Noom (EE. UU.), Atentiv (EE. UU.), Cognoa (EE. UU.), Kaia Health (EE. UU.), Ginger (EE. UU.), Livongo Health (EE. UU.), Mango Health (EE. UU.), Natural Cycles (Suecia), Cognifit (EE. UU.), Fitbit, Inc. (EE. UU.), Omada Health Propeller Health (EE. UU.), Welldoc, Inc. (EE. UU.), Smart Patient GMBH (Alemania), Mindstrong Health (EE. UU.), Ayogo Health (Canadá), Better Therapeutics (EE. UU.), 2morrow (EE. UU.), Canary Health (EE. UU.), Click Therapeutics (EE. UU.), Pear Therapeutics (EE. UU.), Voluntis (EE. UU.), Akili Interactive Labs (EE. UU.), Samsung (Corea), Resmed (EE. UU.) y GAIA AG (Alemania), entre otros. |
Dinámica del mercado de terapia digital (DTx) en Europa y América del Norte
Conductores
- Aumento de la prevalencia de enfermedades crónicas
La creciente prevalencia de enfermedades como la diabetes, la hipertensión y el asma, entre otras, ha provocado una creciente demanda de productos terapéuticos digitales. Las personas quieren obtener opciones de tratamiento asequibles y cómodas de forma rápida y sencilla. Digital Therapeutic es una de esas plataformas que ofrece estos servicios de forma muy sencilla y fácil de usar. Con la creciente prevalencia de enfermedades crónicas y la mayor demanda de productos terapéuticos digitales, esta plataforma resulta muy útil para los pacientes. Se requiere un avance y Digital Therapeutic ofrece dichos servicios, lo que ayudaría al crecimiento del mercado terapéutico digital (DTx) de América del Norte y Europa.
La prevalencia de enfermedades crónicas es el factor impulsor más importante del mercado, por lo que se espera que este caso actúe como impulsor del crecimiento del mercado.
- Aumento de la concienciación por parte de los organismos gubernamentales
La creciente conciencia entre los proveedores, pagadores y empleadores sobre las diferentes ventajas que estos productos/servicios brindan, así como el costo de la atención médica, ayuda a impulsar el crecimiento del mercado. El Centro de Excelencia en Salud Digital (DHCoE), parte del crecimiento organizado del Programa de Salud Digital en el Centro de Dispositivos y Salud Radiológica (CDRH), se había alineado y armonizado con el trabajo de salud digital más allá de la FDA. Había notado el comienzo de un enfoque amplio hacia la tecnología de salud digital, sentando las bases para promover y comprender la posibilidad de la salud digital.
La Sociedad de Medicina Digital (DiMe) es una corporación profesional pionera que reúne a especialistas de todas las autoridades que abarcan las distintas áreas de la medicina digital. DiMe existe para facilitar la medicina digital con el fin de desarrollar la salud humana. Los objetivos que ofrece son la comunicación y la educación, la investigación y la creación de una comunidad. Se espera que estas estrategias actúen como un motor del crecimiento del mercado.
Oportunidades
- Demanda creciente de terapias digitales
La demanda de terapias digitales está aumentando, ya que brindan las siguientes cosas: bienestar físico y mental, prevención, cuidado personal, atención dividida y toma de decisiones compartida, manejo de enfermedades a largo plazo y uso correcto de atención de urgencia y emergencia.
Las terapias digitales brindan acceso a un nivel óptimo de servicios de atención médica, soluciones innovadoras en todos los niveles, soluciones de atención médica asequibles para los pagadores, los beneficiarios y la sociedad, la calidad de la prestación de la atención médica y los resultados de las soluciones se pueden ver, la centralidad en el paciente, la personalización para la satisfacción tanto del paciente como del personal, y también brindan un diagnóstico y una acción más rápidos basados en los datos proporcionados y la prevención a través de la educación, la información, el empoderamiento y los sistemas de alerta. Por lo tanto, se espera que la creciente demanda de terapias digitales actúe como una oportunidad en el crecimiento del mercado.
Restricciones
- Políticas de privacidad de la información del paciente
La privacidad es el principal obstáculo para la terapéutica digital. Las personas están más interesadas en recibir tratamiento a través de proveedores de atención médica tradicionales. Estas aplicaciones requieren cierta información personal que los pacientes no quieren revelar y desean mantener en secreto. Por lo tanto, ciertos factores de privacidad obstaculizarían el crecimiento del mercado.
Además, la información de salud personal ya no es privada: estas aplicaciones toman la información sin preocupación y la comparten con terceros, como en las redes sociales, para publicidad.
Por lo tanto, se espera que las preocupaciones sobre la privacidad relacionadas con las aplicaciones terapéuticas digitales actúen como una restricción al crecimiento del mercado.
Desafíos
- Validación clínica
Las empresas necesitan obtener una validación clínica antes de comercializar su producto. En algunos casos, necesitarán la aprobación de la FDA. Estos procedimientos llevan mucho tiempo y, a veces, no arrojan resultados positivos.
Dado que estos estudios clínicos relacionados con la terapéutica digital toman tiempo para finalizar, se espera que esto represente un desafío para el mercado.
El informe de mercado de terapia digital (DTx) de América del Norte y Europa proporciona detalles de los nuevos desarrollos recientes, regulaciones comerciales, análisis de importación y exportación, análisis de producción, optimización de la cadena de valor, participación de mercado, el impacto de los actores del mercado nacional y localizado, analiza las oportunidades en términos de bolsillos de ingresos emergentes, cambios en las regulaciones del mercado, análisis estratégico del crecimiento del mercado, tamaño del mercado, crecimientos del mercado de categorías, nichos de aplicación y dominio, aprobaciones de productos, lanzamientos de productos, expansiones geográficas, innovaciones tecnológicas en el mercado. Para obtener más información sobre el mercado de terapia digital (DTx), comuníquese con Data Bridge Market Research para obtener un informe de analista. Nuestro equipo lo ayudará a tomar una decisión de mercado informada para lograr el crecimiento del mercado.
Desarrollo reciente
- En enero de 2023, Pear Therapeutics, Inc. (Nasdaq: PEAR), líder en el desarrollo y comercialización de medicamentos basados en software denominados terapias digitales de prescripción (PDT), anunció la inclusión de sus PDT reSET® y reSET-O® en la Lista de medicamentos preferidos (PDL) de Medicaid de Florida de enero de 2023. reSET y reSET-O, las únicas PDT autorizadas por la FDA para el tratamiento del trastorno por consumo de sustancias y el trastorno por consumo de opioides, respectivamente, se han agregado a la PDL de Medicaid de Florida, a partir del 1 de enero de 2023.
- En diciembre de 2022, Click Therapeutics, Inc. (“Click”), líder en Digital Therapeutics™ como tratamientos médicos de prescripción, anunció que había recibido la designación de dispositivo innovador de la Administración de Alimentos y Medicamentos de los EE. UU. (FDA) para CT-132. La terapia digital de prescripción CT-132 de Click está en desarrollo como tratamiento preventivo complementario para la migraña episódica en pacientes de 18 años o más.
Segmentación del mercado de terapia digital (DTx) en Europa y América del Norte
El mercado de terapia digital (DTx) de América del Norte y Europa se clasifica en cuatro segmentos importantes, que se basan en el tipo de producto y servicio, la aplicación, el modo de compra y el canal de venta. El crecimiento entre segmentos le ayuda a analizar nichos de crecimiento y estrategias para abordar el mercado y determinar sus áreas de aplicación principales y la diferencia en sus mercados objetivo.
Tipo de producto y servicio
- PRODUCTOS DE HARDWARE
- SOLUCIONES/SOFTWARE
- SERVICIO
Sobre la base del tipo de producto y servicio, el mercado terapéutico digital (DTx) de América del Norte y Europa está segmentado en productos de hardware, soluciones/software y servicios.
POR APLICACIÓN
- APLICACIONES RELACIONADAS CON EL TRATAMIENTO/ATENCIÓN
- APLICACIONES PREVENTIVAS
Sobre la base de la aplicación, el mercado terapéutico digital (DTx) de América del Norte y Europa está segmentado en aplicaciones relacionadas con el tratamiento/cuidado y aplicaciones preventivas.
POR MODO DE COMPRA
- ORGANIZACIÓN DE COMPRAS EN GRUPO
- INDIVIDUAL
Sobre la base del modo de compra, el mercado terapéutico digital (DTx) de América del Norte y Europa está segmentado en organizaciones de compra grupal e individuales.
POR CANAL DE VENTA
- B2B
- De empresa a consumidor
Sobre la base del canal de ventas, el mercado terapéutico digital (DTx) de América del Norte y Europa está segmentado en B2B y B2C.
Análisis y perspectivas regionales del mercado de terapia digital (DTx)
Se analiza el mercado terapéutico digital (DTx) y se proporcionan información y tendencias del tamaño del mercado por país, tipo de producto y servicio, aplicación, modo de compra y canal de ventas.
El mercado terapéutico digital (DTx) comprende los países de EE. UU., Canadá, México, Alemania, Reino Unido, Francia, Italia, España, Países Bajos, Rusia, Suiza, Turquía, Bélgica y el resto de Europa.
Se espera que América del Norte domine el mercado terapéutico digital (DTx) debido a la creciente conciencia entre los consumidores sobre los beneficios para la salud de las microalgas y al aumento de la demanda de productos de microalgas.
La sección de países del informe también proporciona factores individuales que impactan en el mercado y cambios en la regulación del mercado que afectan las tendencias actuales y futuras del mercado. El análisis de los puntos de datos de la cadena de valor aguas abajo y aguas arriba, el análisis de las cinco fuerzas de Porter de las tendencias técnicas y los estudios de casos son algunos de los indicadores utilizados para pronosticar el escenario del mercado para cada país. Además, se consideran la presencia y disponibilidad de marcas de América del Norte y los desafíos que enfrentan debido a la gran o escasa competencia de las marcas locales y nacionales, el impacto de los aranceles nacionales y las rutas comerciales al proporcionar un análisis de pronóstico de los datos del país.
Análisis del panorama competitivo y de la cuota de mercado de la atención sanitaria domiciliaria
El panorama competitivo del mercado de terapia digital (DTx) de América del Norte y Europa proporciona detalles por competidores. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y la variedad de productos y el dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en el mercado de terapia digital (DTx) heredado de América del Norte y Europa.
Algunos de los principales actores que operan en el mercado terapéutico digital (DTx) de América del Norte y Europa son: SAMSUNG, Voluntis, Livongo, Fitbit, Inc., ResMed, Natural Cycles USA Corp, GAIA AG, Smartpatient gmbh, Kaia Health, Pear Therapeutics Inc., entre otros.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT AND SERVICE TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, INDUSTRY INSIGHT
CONCLUSION: 53
6 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, REGULATION
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISE IN THE PREVALENCE OF CHRONIC DISEASES
7.1.2 INCREASE IN AWARENESS BY GOVERNMENT AGENCIES
7.1.3 TECHNOLOGICAL ADVANCEMENT IN HEALTHCARE
7.1.4 INCREASED NUMBER OF PEOPLE USING SMARTPHONES
7.1.5 IMPROVED QUALITY OF LIFE
7.2 RESTRAINTS
7.2.1 PATIENT INFORMATION PRIVACY POLICIES
7.2.2 DIGITAL PAYMENT ASSOCIATED WITH DIGITAL THERAPEUTICS
7.2.3 UNDERDEVELOPED COUNTRIES LACKING SMARTPHONES AND INTERNET FACILITIES
7.3 OPPORTUNITIES
7.3.1 RISING DEMAND FOR DIGITAL THERAPEUTICS
7.3.2 COLLABORATION BETWEEN COMPANIES TO PROVIDE BETTER PRODUCTS/SERVICES
7.3.3 PARTNERSHIP BETWEEN COMPANIES
7.3.4 EXPANSION AND LAUNCH OF PRODUCTS
7.3.5 EVENTS AND EXHIBITION
7.3.6 PHYSICIAN ADOPTION
7.4 CHALLENGES
7.4.1 CLINICAL VALIDATION
7.4.2 REGULATORY APPROVAL
7.4.3 PAYER REIMBURSEMENT
8 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE
8.1 OVERVIEW
8.2 SOLUTIONS/SOFTWARE
8.3 HARDWARE PRODUCTS
8.4 SERVICE
9 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 TREATMENT/CARE-RELATED APPLICATIONS
9.2.1 DIABETIS
9.2.1.1 TYPE 2
9.2.1.2 TYPE 1
9.2.2 CENTRAL NERVOUS SYSTEM DISORDERS
9.2.2.1 MENTAL HEALTH DISORDER
9.2.2.2 OTHER CNS DISORDERS
9.2.3 SMOKING CESSATION
9.2.4 CHRONIC RESPIRATORY DISEASES
9.2.4.1 ASTHMA
9.2.4.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE
9.2.4.3 OTHERS
9.2.5 CARDIOVASCULAR DISEASES
9.2.5.1 ARRHYTMIA
9.2.5.2 HEART FAILURE
9.2.5.3 OTHERS
9.2.6 MEDICATION ADHERENCE
9.2.7 ONCOLOGY
9.2.8 GASTROINTESTINAL DISORDERS
9.2.9 REHABILITATION & PATIENT CARE
9.2.10 SUBSTANCE USE DISORDERS & ADDICTION MANAGEMENT
9.2.11 OTHER TREATMENT/CARE-RELATED APPLICATIONS
9.3 PREVENTIVE APPLICATION
9.3.1 HEART ATTACKS
9.3.2 PREDIABETES
9.3.3 OBESITY
9.3.4 NUTRITION
9.3.5 LIFESTYLE MANAGEMENT
9.3.6 OTHER PREVENTIVE APPLICATIONS
10 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE
10.1 OVERVIEW
10.2 GROUP PURCHASE ORGANIZATION
10.3 SOLUTIONS/SOFTWARE
10.4 HARDWARE PRODUCTS
10.5 SERVICE
10.6 INDIVIDUAL
10.6.1 SOLUTIONS/SOFTWARE
10.6.2 HARDWARE PRODUCTS
10.6.3 SERVICE
11 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL
11.1 OVERVIEW
11.2 B2B
11.2.1 PAYERS
11.2.2 EMPLOYERS
11.2.3 PHARMACEUTICAL COMPANIES
11.2.4 PROVIDERS
11.2.5 OTHER BUYERS
11.3 B2C
11.3.1 CAREGIVERS
11.3.2 PATIENTS
12 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET
12.1 NORTH AMERICA
12.1.1 U.S.
12.1.2 CANADA
12.1.3 MEXICO
12.2 EUROPE
12.2.1 GERMANY
12.2.2 FRANCE
12.2.3 ITALY
12.2.4 U.K.
12.2.5 SPAIN
12.2.6 SWITZERLAND
12.2.7 IRELAND
12.2.8 NETHERLANDS
12.2.9 RUSSIA
12.2.10 HUNGARY
12.2.11 TURKEY
12.2.12 AUSTRIA
12.2.13 POLAND
12.2.14 NORWAY
12.2.15 LITHUANIA
12.2.16 REST OF EUROPE
13 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
13.2 COMPANY SHARE ANALYSIS: EUROPE
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 SAMSUNG
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 PRODUCT PORTFOLIO
15.1.4 RECENT DEVELOPMENT
15.2 VOLUNTIS
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 PRODUCT PORTFOLIO
15.2.4 RECENT DEVELOPMENT
15.3 NOOM, INC.
15.3.1 COMPANY SNAPSHOT
15.3.2 PRODUCT PORTFOLIO
15.3.3 RECENT DEVELOPMENT
15.4 FITBIT, INC.
15.4.1 COMPANY SNAPSHOT
15.4.2 PRODUCT PORTFOLIO
15.4.3 RECENT DEVELOPMENTS
15.5 LIVONGO
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENT
15.6 AKILI INTERACTIVE LABS, INC.
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENTS
15.7 ATENTIV
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENTS
15.8 AYOGO HEALTH INC.
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 BETTER THERAPEUTICS, INC
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENTS
15.1 CANARY HEALTH
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENT
15.11 COGNOA
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENTS
15.12 COGNIFIT
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENT
15.13 CLICK THERAPEUTICS, INC.
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 GINGER
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 GAIA AG
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 KAIA HEALTH
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENTS
15.17 MANGO HEALTH
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENT
15.18 MINDSTRONG HEALTH
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENT
15.19 2MORROW INC.
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENTS
15.2 NATURAL CYCLES USA CORP
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENT
15.21 OMADA HEALTH, INC.
15.21.1 COMPANY SNAPSHOT
15.21.2 PRODUCT PORTFOLIO
15.21.3 RECENT DEVELOPMENTS
15.22 PEAR THERAPEUTICS, INC.
15.22.1 COMPANY SNAPSHOT
15.22.2 PRODUCT PORTFOLIO
15.22.3 RECENT DEVELOPMENT
15.23 RESMED
15.23.1 COMPANY SNAPSHOT
15.23.2 REVENUE ANALYSIS
15.23.3 PRODUCT PORTFOLIO
15.23.4 RECENT DEVELOPMENT
15.24 SMARTPATIENT GMBH
15.24.1 COMPANY SNAPSHOT
15.24.2 PRODUCT PORTFOLIO
15.24.3 RECENT DEVELOPMENT
15.25 WELLDOC, INC.
15.25.1 COMPANY SNAPSHOT
15.25.2 PRODUCT PORTFOLIO
15.25.3 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
Lista de Tablas
TABLE 1 REGULATORY FRAMEWORK
TABLE 2 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 3 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 4 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 6 EUROPE TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 8 EUROPE DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 10 EUROPE CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 12 EUROPE CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 14 EUROPE CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 15 NORTH AMERICA CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 16 EUROPE PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 17 NORTH AMERICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 18 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 19 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 20 EUROPE GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 21 NORTH AMERICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 22 EUROPE INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 24 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 26 EUROPE B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 28 EUROPE B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 30 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 31 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 32 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 33 U.S. TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 34 U.S. CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 35 U.S. CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 36 U.S. CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 37 U.S. DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 38 U.S. PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 39 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 40 U.S. GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 41 U.S. INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 42 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 43 U.S. B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 44 U.S. B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 45 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 46 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 47 CANADA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 48 CANADA CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 49 CANADA CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 50 CANADA CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 51 CANADA DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 52 CANADA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 53 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 54 CANADA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 55 CANADA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 56 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 57 CANADA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 58 CANADA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 59 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 60 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 61 MEXICO TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 62 MEXICO CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 63 MEXICO CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 64 MEXICO CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 65 MEXICO DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 66 MEXICO PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 67 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 68 MEXICO GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 69 MEXICO INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 70 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 71 MEXICO B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 72 MEXICO B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 73 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 74 GERMANY DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 75 GERMANY DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 76 GERMANY TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 77 GERMANY CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 78 GERMANY CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 79 GERMANY CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 80 GERMANY DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 81 GERMANY PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 82 GERMANY DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 83 GERMANY GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 84 GERMANY INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 85 GERMANY DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 86 GERMANY B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 87 GERMANY B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 88 FRANCE DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 89 FRANCE DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 90 FRANCE TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 91 FRANCE CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 92 FRANCE CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 93 FRANCE CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 94 FRANCE DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 95 FRANCE PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 96 FRANCE DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 97 FRANCE GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 98 FRANCE INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 99 FRANCE DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 100 FRANCE B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 101 FRANCE B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 102 ITALY DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 103 ITALY DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 104 ITALY TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 105 ITALY CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 106 ITALY CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 107 ITALY CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 108 ITALY DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 109 ITALY PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 110 ITALY DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 111 ITALY GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 112 ITALY INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 113 ITALY DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 114 ITALY B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 115 ITALY B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 116 U.K. DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 117 U.K. DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 118 U.K. TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 119 U.K. CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 120 U.K. CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 121 U.K. CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 122 U.K. DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 123 U.K. PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 124 U.K. DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 125 U.K. GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 126 U.K. INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 127 U.K. DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 128 U.K. B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 129 U.K. B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 130 SPAIN DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 131 SPAIN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 132 SPAIN TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 133 SPAIN CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 134 SPAIN CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 135 SPAIN CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 136 SPAIN DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 137 SPAIN PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 138 SPAIN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 139 SPAIN GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 140 SPAIN INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 141 SPAIN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 142 SPAIN B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 143 SPAIN B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 144 SWITZERLAND DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 145 SWITZERLAND DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 146 SWITZERLAND TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 147 SWITZERLAND CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 148 SWITZERLAND CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 149 SWITZERLAND CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 150 SWITZERLAND DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 151 SWITZERLAND PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 152 SWITZERLAND DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 153 SWITZERLAND GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 154 SWITZERLAND INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 155 SWITZERLAND DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 156 SWITZERLAND B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 157 SWITZERLAND B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 158 IRELAND DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 159 IRELAND DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 160 IRELAND TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 161 IRELAND CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 162 IRELAND CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 163 IRELAND CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 164 IRELAND DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 165 IRELAND PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 166 IRELAND DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 167 IRELAND GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 168 IRELAND INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 169 IRELAND DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 170 IRELAND B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 171 IRELAND B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 172 NETHERLANDS DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 173 NETHERLANDS DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 174 NETHERLANDS TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 175 NETHERLANDS CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 176 NETHERLANDS CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 177 NETHERLANDS CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 178 NETHERLANDS DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 179 NETHERLANDS PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 180 NETHERLANDS DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 181 NETHERLANDS GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 182 NETHERLANDS INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 183 NETHERLANDS DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 184 NETHERLANDS B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 185 NETHERLANDS B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 186 RUSSIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 187 RUSSIA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 188 RUSSIA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 189 RUSSIA CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 190 RUSSIA CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 191 RUSSIA CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 192 RUSSIA DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 193 RUSSIA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 194 RUSSIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 195 RUSSIA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 196 RUSSIA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 197 RUSSIA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 198 RUSSIA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 199 RUSSIA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 200 HUNGARY DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 201 HUNGARY DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 202 HUNGARY TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 203 HUNGARY CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 204 HUNGARY CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 205 HUNGARY CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 206 HUNGARY DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 207 HUNGARY PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 208 HUNGARY DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 209 HUNGARY GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 210 HUNGARY INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 211 HUNGARY DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 212 HUNGARY B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 213 HUNGARY B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 214 TURKEY DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 215 TURKEY TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 216 TURKEY TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 217 TURKEY CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 218 TURKEY CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 219 TURKEY CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 220 TURKEY DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 221 TURKEY PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 222 TURKEY DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 223 TURKEY GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 224 TURKEY INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 225 TURKEY DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 226 TURKEY B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 227 TURKEY B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 228 AUSTRIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 229 AUSTRIA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 230 AUSTRIA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 231 AUSTRIA CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 232 AUSTRIA CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 233 AUSTRIA CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 234 AUSTRIA DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 235 AUSTRIA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 236 AUSTRIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 237 AUSTRIA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 238 AUSTRIA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 239 AUSTRIA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 240 AUSTRIA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 241 AUSTRIA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 242 POLAND DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 243 POLAND DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 244 POLAND TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 245 POLAND CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 246 POLAND CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 247 POLAND CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 248 POLAND DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 249 POLAND PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 250 POLAND DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 251 POLAND GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 252 POLAND INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 253 POLAND DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 254 POLAND B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 255 POLAND B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 256 NORWAY DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 257 NORWAY DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 258 NORWAY TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 259 NORWAY CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 260 NORWAY CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 261 NORWAY CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 262 NORWAY DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 263 NORWAY PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 264 NORWAY DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 265 NORWAY GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 266 NORWAY INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 267 NORWAY DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 268 NORWAY B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 269 NORWAY B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 270 LITHUANIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)
TABLE 271 LITHUANIA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 272 LITHUANIA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 273 LITHUANIA CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 274 LITHUANIA CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 275 LITHUANIA CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 276 LITHUANIA DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 277 LITHUANIA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 278 LITHUANIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 279 LITHUANIA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 280 LITHUANIA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)
TABLE 281 LITHUANIA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 282 LITHUANIA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 283 LITHUANIA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)
TABLE 284 REST OF EUROPE DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)
Lista de figuras
FIGURE 1 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: SEGMENTATION
FIGURE 2 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: DROC ANALYSIS
FIGURE 4 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: MULTIVARIATE MODELLING
FIGURE 7 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: SEGMENTATION
FIGURE 12 THE INCREASING DEMAND FOR DIGITAL THERAPEUTICS IS INCREASING WORLDWIDE DUE TO THE PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE MARKET GROWTH IN THE FORECAST PERIOD OF 2023 TO 2030.
FIGURE 13 SOLUTIONS/ SOFTWARES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET IN 2023 & 2030
FIGURE 14 SOLUTIONS/ SOFTWARES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE DIGITAL THERAPEUTIC (DTX) MARKET IN 2023 & 2030
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET
FIGURE 16 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2022
FIGURE 17 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2023-2030 (USD MILLION)
FIGURE 18 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, CAGR (2023-2030)
FIGURE 19 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, LIFELINE CURVE
FIGURE 20 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2022
FIGURE 21 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2023-2030 (USD MILLION)
FIGURE 22 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, CAGR (2023-2030)
FIGURE 23 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, LIFELINE CURVE
FIGURE 24 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2022
FIGURE 25 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 26 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 27 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 28 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2022
FIGURE 29 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 30 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 31 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 32 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2022
FIGURE 33 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2023-2030 (USD MILLION)
FIGURE 34 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, CAGR (2023-2030)
FIGURE 35 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, LIFELINE CURVE
FIGURE 36 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2022
FIGURE 37 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2023-2030 (USD MILLION)
FIGURE 38 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, CAGR (2023-2030)
FIGURE 39 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, LIFELINE CURVE
FIGURE 40 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2022
FIGURE 41 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2023-2030 (USD MILLION)
FIGURE 42 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, CAGR (2023-2030)
FIGURE 43 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, LIFELINE CURVE
FIGURE 44 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2022
FIGURE 45 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2023-2030 (USD MILLION)
FIGURE 46 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, CAGR (2023-2030)
FIGURE 47 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, LIFELINE CURVE
FIGURE 48 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: SNAPSHOT (2022)
FIGURE 49 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2022)
FIGURE 50 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2023 & 2030)
FIGURE 51 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2022 & 2030)
FIGURE 52 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: PRODUCT AND SERVICE TYPE (2023-2030)
FIGURE 53 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: SNAPSHOT (2022)
FIGURE 54 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2022)
FIGURE 55 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2023 & 2030)
FIGURE 56 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2022 & 2030)
FIGURE 57 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: PRODUCT AND SERVICE TYPE (2023-2030)
FIGURE 58 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY SHARE 2022 (%)
FIGURE 59 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY SHARE 2022 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
